Abstract
Background: Pathologists can distinguish benign phyllodes tumors, which very rarely metastasize, from malignant phyllodes tumors, which metastasize in approximately one fourth of patients. However, whether these same histologic criteria can be used to predict the likelihood that a phyllodes tumor will locally recur after breast conserving therapy remains controversial.
Study Design: Since few patients with malignant phyllodes tumors have been treated with breast conserving surgery in any individual series, the literature was reviewed using a Medline search.
Results: After local excision, 21 (111/540), 46 (18/39), and 65 (26/40) of patients with benign, borderline, and malignant phyllodes tumors, respectively, recurred in the breast. Following wide local excision, 8 (17/212), 29 (20/68), and 36 (16/45) of patients with benign, borderline, and malignant phyllodes tumors recurred in the breast.
Conclusions: Malignant phyllodes tumors are much more likely than benign phyllodes tumors to recur in the breast after breast conserving surgery. This high rate of local recurrence of borderline and malignant phyllodes tumors suggests that wide local excision is less than optimal therapy, and challenges us to look for methods to improve local tumor control.
Similar content being viewed by others
References
Pietruszka M, Barnes L: Cystosarcoma phyllodes. Cancer 41: 1974–dy1983, 1978
Haagensen C: Cystosarcoma phyllodes. In: Haagensen C (ed) Diseases of the Breast. 3rd edition. WB Saunders, Phil., 1986, pp 284–312
Rosai J: Phyllodes tumor. In: Rosai J (ed) Ackerman's Surgical Pathology. 8th edition. Mosby, Boston, 1996, pp 1628–1630
Petrek J: Cystosarcoma phyllodes. In: Harris J, Hellman S, Henderson I, Kinne D (eds) Breast Diseases. 3rd edition. JB Lippincott, Phil., 1996, pp 791–797
Bernstein L, Deapen D, Ross R: The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast. Cancer 71: 3020-3024, 1993
Moffat C, Pinder S, Dixon A, Elston C, Blamey R, Ellis I: Phyllodes tumors of the breast: a clinicopathological review of thirty-two cases. Histopathology 27: 205–218, 1995
Kario K, Maeda S, Mizuno Y, Makino Y, Tankawa H, Kitazawa S: Phyllodes tumor of the breast: a clinicopathologic study of 34 cases. J Surg Oncol 45: 46–51, 1990
Halverson J, Hori-Rubaina J: Cystosarcoma phyllodes of the breast. Am Surg 40: 295–301, 1974
Grimes M: Cystosarcoma phyllodes of the breast. Modern Pathol 5: 232–239, 1992
Ward R, Evans H: Cystosarcoma phyllodes. Cancer 58: 2282–2289, 1986
Bennett I, Khan A, DeFrietas R, Chaudary M, Millis R: Phyllodes tumors: a clinicopathological review of 30 cases. Aust NZ J Surg 62: 628–633, 1992
Rowell M, Perry R, Hsiu J, Barranco S: Phyllodes tumors. Am J Surg 165: 376–379, 1993
Azzopardi J: Problems in Breast Pathology. WB Saunders, 1979, pp 346–365
Salvadori B, Cusumano F, del Bo R, Delledonne V, Grassi M, Rovini D, Saccozzi R, et al.: Surgical treatment of phyllodes tumors of the breast. Cancer 63: 2532–2536, 1989
Ciatto S, Bonardi R, Cataliotti L, Cardona G: Phyllodes tumor of the breast: a multicenter series of 59 cases. Eur J Surg Oncology 18: 545–549, 1992
Reinfuss M, Mitus J, Duda K, Stelmach A, Rys J, Smolak K: The treatment and prognosis of patients with phyllodes tumor of the breast. Cancer 77: 910-916, 1996
Hajdu S, Espinosa M, Robbins G: Recurrent cystosarcoma phyllodes. Cancer 38: 1402–1406, 1976
Treves N, Sunderland D: Cystosarcoma phyllodes of the breast: a malignant and a benign tumor. Cancer 4: 1286–1332, 1951
Zurrida 5, Bartoli C, Galimberti V, Squicciarini P, Delledonne V, Veronesi P, Bono A, et al.: Which therapy for unexpected phyllode tumor of the breast? Eur J Cancer 28: 654–657, 1992
Lester J, Stout A: Cystosarcoma phyllodes. Cancer 7: 335–353, 1954
Oberman H: Cystosarcoma phyllodes. Cancer 18: 697–710, 1965
Contarini O, Urdaneta L, Hagen W, Stephenson S: Cystosarcoma phyllodes of the breast. Am Surg 48: 157–165, 1982
Hines J, Murad T, Beal J: Prognostic indicators in cystosarcoma phyllodes. Am J Surg 153: 276–280, 1987
Hart J, Layfield L, Trumball W, Brayton D, Barker W, Giuliano A: Practical aspects in the diagnosis and management of cystosarcoma phyllodes. Arch Surg 123: 1079–1083, 1988
Chua C, Thomas A, Ng B: Cystosarcoma phyllodes: a review of surgical options. Surgery 105: 141–147, 1989
Chatson G, Anderson C, Berman M, Deckers P: Phyllodes tumors. Contemp Surg 40: 36–41, 1992
Stebbing J, Nash A: Diagnosis and management of phyllodes tumor of the breast: experience of 33 cases at a specialist centre. Ann R Coll Surg Engl 77: 181–184, 1995
Hopkins M, McGowan T, Rawlings G, Liu F, Fyles A, Yeoh J, Manchul L, et al.: Phyllodes tumor of the breast: a report of 14 cases. J Surg Oncol 56: 108–112, 1994
Grigioni W, Santini D, Grassigli A, Taffurelli M, Milani M, Vanzo M, Marrano D: A clinico-pathologic study of cystosarcoma phyllodes. Arch Anat Cytol Path 30: 303–306, 1982
Modena S, Prati G, Mainente M, Massocco A, Montresor E, Pelosi G, Iannucci A: Phyllodes tumor of the breast. Eur J Surg Oncol 19: 70–73, 1993
Staren E, Lynch G, Boyle C, Witt T, Bines S: Malignant cystosarcoma phyllodes. Am Surg 60: 583–585, 1994
Palmer M, DeRisi D, Pelikan A, Patel J, Nemoto T, Rosner D, Dao T: Treatment options and recurrence patterns for cystosarcoma phyllodes. Surg Gyn Obst 170: 193–196, 1990
Reinfuss M, Mitus J, Smolak K, Stelmach A: Malignant phyllodes tumors of the breast. Eur J Cancer 29A: 1252–1256, 1993
Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerham L, Fisher E, et al.: Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. NEJM 320: 822–828, 1989
Veronesi U, Luini A, Del Vecchio M, Greco M, Galimberti V, Merson M, Rilke F, et al.: Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. NEJM 328: 1587–1591, 1993
Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, Fisher E, et al.: Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16: 441–452, 1998
Marcus S, Merino M, Glatstein E, et al.: Long-term outcome in 87 patients with low-grade soft-tissue sarcoma. Arch Surg 128: 1336–1343, 1993
Suit H, Russell W, Martin R: Sarcoma of soft tissue: clinical and histopathologic parameters and response to treatment. Cancer 35: 1478, 1975
Pisters P, Harrison L, Leung D, et al.: Long term results of a prospective randomized trial evaluating the role of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 14: 859, 1996
Hoover H, Testioteanu A, Ketcham A: Metastatic cystosarcoma phyllodes in an adolescent girl. Ann Surg 181: 279–282, 1975
Burton G, Hart L, Leight G, Iglehart I, McCarty K, Cox E: Cystosarcoma phyllodes, effective therapy with cisplatin and etoposide chemotherapy. Cancer 63: 2088–2092, 1989
Thomas A, Ashworth B, Blake P: Regression of recurrent cystosarcoma phyllodes tumor after neutron treatment. Br J Rad 57: 926–929, 1984
Allen R, Nixon D, York M, Coleman J: Successful chemotherapy for cystosarcoma phyllodes. Arch Int Med 145: 1127–1128, 1985
Turalba C, El-Mahdi A, Ladga L: Fatal metastatic cystosarcoma phyllodes. J Surg Oncol 33: 176–781, 1986
Rissanen P, Holsti P: A retrospective study of sarcoma of the breast. Oncology 22: 258–268, 1968
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barth, R.J. Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors. Breast Cancer Res Treat 57, 291–295 (1999). https://doi.org/10.1023/A:1006260225618
Issue Date:
DOI: https://doi.org/10.1023/A:1006260225618